Similar articles

• Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.

  Ballard CG, O'Brien JT, Reichelt K, Perry EK. Ballard CG, et al. J Clin Psychiatry. 2002 Jul;63(7):553-8. doi: 10.4088/jcp.v63n0703. J Clin Psychiatry. 2002. PMID: 12143909 Clinical Trial.
• Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory.

  Zuidema SU, Buursema AL, Gerritsen MG, Oosterwal KC, Smits MM, Koopmans RT, de Jonghe JF. Zuidema SU, et al. Int J Geriatr Psychiatry. 2011 Feb;26(2):127-34. doi: 10.1002/gps.2499. Int J Geriatr Psychiatry. 2011. PMID: 20690131
• Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument.

  Cohen-Mansfield J. Cohen-Mansfield J. Int Psychogeriatr. 1996;8 Suppl 3:309-15; discussion 351-4. doi: 10.1017/s1041610297003530. Int Psychogeriatr. 1996. PMID: 9154580 Review. No abstract available.
• Effects of aromatherapy on agitation and related caregiver burden in patients with moderate to severe dementia: A pilot study.

  Turten Kaymaz T, Ozdemir L. Turten Kaymaz T, et al. Geriatr Nurs. 2017 May-Jun;38(3):231-237. doi: 10.1016/j.gerinurse.2016.11.001. Epub 2016 Nov 29. Geriatr Nurs. 2017. PMID: 27912905
• Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.

  De Deyn PP, Wirshing WC. De Deyn PP, et al. J Clin Psychiatry. 2001;62 Suppl 21:19-22. J Clin Psychiatry. 2001. PMID: 11584983 Review.